Treatment of Anemia With Erythropoietin-Stimulating Agents in Kidney Transplant Recipients and Chronic Kidney Disease—Another Drawback of Immunosuppression?-Reference-Cited by-同舟云学术

Treatment of Anemia With Erythropoietin-Stimulating Agents in Kidney Transplant Recipients and Chronic Kidney Disease—Another Drawback of Immunosuppression?

Published:2012-12 Issue:10 Volume:44 Page:3013-3016
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Malyszko J.,Glowinska I.,Mysliwiec M.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference29 articles.

1. after kidney transplantation is not completely explained by reduced kidney function;Chadban;Am J Kidney Dis,2007

2. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres;Molnar;Nephron Clin Pract,2010

3. Anemia and iron deficiencies among long-term renal transplant recipients;Lorenz;J Am Soc Nephrol,2002

4. Late post-transplant anemia in adult renal transplant recipients;Yorgin;Am J Transplant,2002

5. Anemia after renal transplantation;Afzali;Am J Kidney Dis,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia in Chronic Renal Disease;Pediatric Kidney Disease;2023

2. Extended Literature Review of the role of erythropoietin stimulating agents (ESA) use in the management of post renal transplant anaemia;Transplantation Reports;2022-06

3. Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients;Journal of Pharmaceutical Health Services Research;2021-06-10

4. Haematological disorders following kidney transplantation;Nephrology Dialysis Transplantation;2020-11-05

5. Current and Novel Drugs for Management of Anemia;Management of Anemia;2017-10-13